In this case, we first reported targeted comutation of somatic novel KANK1-ALK, UPP2 intergenic NTRK3 fusion, and pathogenetic germline BRCA1 mutation in a pancreatic ductal adenocarcinoma patient. Here, KANK1 is linked to pancreatic ductal adenocarcinoma.